12594 Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–4953 Filed 2–29–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Decision To Evaluate a Petition To 

Designate a Class of Employees From 

the Rocky Flats Plant in Golden, CO, 

To Be Included in the Special 

Exposure Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services. 

ACTION: Notice. 

SUMMARY: NIOSH gives notice as 

required by 42 CFR 83.12(e) of a 

decision to evaluate a petition to 

designate a class of employees from the 

Rocky Flats Plant in Golden, Colorado, 

to be included in the Special Exposure 

Cohort under the Energy Employees 

Occupational Illness Compensation 

Program Act of 2000. The initial 

proposed definition for the class being 

evaluated, subject to revision as 

warranted by the evaluation, is as 

follows: 

Facility: Rocky Flats Plant. 

Location: Golden, Colorado. 

Job Titles and/or Job Duties: All 

employees of the Department of Energy, 

its predecessor agencies, and their 

contractors and subcontractors. 

Period of Employment: January 1, 

1972 through December 31, 1989. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

National Institute for Occupational 

Safety and Health, 4676 Columbia 

Parkway, MS C–46, Cincinnati, OH 

45226, Telephone 877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2012–4961 Filed 2–29–12; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[30-Day–12–12BL] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Agency for Toxic Substances and 

Disease Registry (ATSDR) publishes a 

list of information collection requests 

under review by the Office of 

Management and Budget (OMB) in 

compliance with the Paperwork 

Reduction Act (44 U.S.C. Chapter 35). 

To request a copy of these requests, call 

the Centers for Disease Control and 

Prevention (CDC) Reports Clearance 

Officer at (404) 639–7570 or send an 

email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC 20503 or by fax to (202) 395–5806. 

Written comments should be received 

within 30 days of this notice. 

Proposed Project 

Biomonitoring of Great Lakes 

Populations Program—New—Agency 

for Toxic Substances and Disease 

Registry (ATSDR), Centers for Disease 

Control and Prevention (CDC). 

Background and Brief Description 

The Great Lakes Basin has suffered 

decades of pollution and ecosystem 

damage. In 1987, the Great Lakes Water 

Quality Agreement listed 40 Areas of 

Concern (AOCs) representing the most 

polluted areas in the Great Lakes Basin. 

Many chemicals persist in Great Lakes 

sediments, as well as in wildlife and 

humans. These chemicals can build up 

in the aquatic food chain. Eating 

contaminated fish is a known route of 

human exposure. 

In 2009, the Great Lakes Restoration 

Initiative (GLRI) was enacted in Public 

Law 111–88. The GLRI makes Great 

Lakes restoration a national priority for 

16 federal agencies. The GLRI is led by 

the U.S. Environmental Protection 

Agency (U.S. EPA). Under a 2010 

interagency agreement with the U.S. 

EPA, the Agency for Toxic Substances 

and Disease Registry (ATSDR) 

announced a funding opportunity called 

the ‘‘Biomonitoring of Great Lakes 

Populations Program’’ (CDC–RFA– 

TS10–1001). 

This applied public health program 

aims to measure Great Lakes chemicals 

in human blood and urine. These 

measures will be a baseline for the GLRI 

and future restoration activities. The 

measures will be compared to available 

national estimates. This program also 

aims to take these measures from people 

who may be at higher risk of harm from 

chemical exposures. 

Three states were funded for this 

program: Michigan, Minnesota, and 

New York. The health departments in 

these states will look at seven AOCs and 

four types of sensitive adults: 

Michigan—urban anglers in the Detroit 

River and the Saginaw River and Bay 

AOCs; Minnesota—American Indians 

near the St. Louis River AOC; and New 

York—licensed anglers and immigrants 

from Burma and their family members 

living in four Lake Ontario and Lake 

Erie AOCs. These include the Rochester 

Embayment AOC, the Eighteenmile 

Creek AOC, and the AOCs along the 

Niagara and Buffalo Rivers. 

Each state will use its own way to ask 

people to take part in the study. In 

Michigan, people fishing along the 

shores of the Detroit River and Saginaw 

River and Bay will be asked a few 

questions to see if they are willing to 

take part in the study. In Minnesota, 

American Indians will be randomly 

chosen from a list of people who get 

local tribal health clinic and social 

services. They will be contacted by 

trained staff to take part in the study. In 

New York, names from the state 

licensed angler database will be chosen 

at random. These people will be 

contacted by mail and telephone to take 

part in the study. Another group, 

immigrants who moved from Burma to 

Buffalo, NY, will work with trained 

study staff to get their people to take 

part in the study. 

All respondents who consent will 

give blood and urine specimens. Their 

blood and urine will be tested for 

polychlorinated biphenyls (PCBs), 

mercury, lead, and pesticides. Pesticides 

will include mirex, hexachlorobenzene, 

dichlorodiphenyltrichloroethane (DDT) 

and dichlorodiphenyldichloroethylene 

(DDE). Each state will test blood and 

urine for other chemicals of local 

concern. Respondents will also be 

interviewed. They will be asked about 

demographic and lifestyle factors, 

hobbies, and types of jobs, which can 

contribute to chemical exposure. Some 

diet questions will be asked, too, with 

a focus on eating Great Lakes fish. There 

is no cost to respondents other than 

their time spent in the study. The 

estimated annualized burden hours are 

713 hours. The ATSDR is requesting 

approval to conduct this information 

collection for two years. 

The ATSDR is authorized to conduct 

this program under the Comprehensive 

Environmental Response, 

Compensation, and Liability Act of 

1980, as amended by the Superfund 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices 12595 

Amendments and Reauthorization Act 

of 1986. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Michigan Shoreline Anglers ............................ Screening Questionnaire ................................ 350 1 5/60 

Telephone Questions for Scheduling Appointments.250 1 7/60 

Informed Consent ........................................... 200 1 1/60 

Biomonitoring Questionnaire .......................... 200 1 54/60 

American Indians from Minnesota .................. Recruitment Calling Script ............................. 312 1 5/60 

Refusal Questions Form ................................ 62 1 2/60 

Individual Consent Form ................................ 250 1 3/60 

Contact Information Form .............................. 250 1 2/60 

Study Participant Questionnaire .................... 250 1 30/60 

Clinic Visit Form ............................................. 250 1 1/60 

Participation Record ....................................... 250 1 3/60 

New York State Licensed Anglers .................. Mail-in Eligibility Screening Survey ................ 300 1 5/60 

Online Eligibility Screening Survey ................ 450 1 5/60 

Telephone Script for Non-responders to 

Screening.

500 1 5/60 

Telephone Script for Eligible Responders to 

Screening.

150 1 5/60 

Informed Consent ........................................... 200 1 1/60 

Interview Questionnaire ................................. 200 1 30/60 

Immigrants from Burma and Descendants ..... Eligibility Screening Survey ............................ 92 1 5/60 

Informed Consent ........................................... 50 1 1/60 

Interview Questionnaire ................................. 50 1 1 

Network Size Questions for Respondent 

Driven Sampling.

50 1 5/60 

Kimberly S. Lane, 

Reports Clearance Officer, Centers for Disease 

Control and Prevention. 

[FR Doc. 2012–4947 Filed 2–29–12; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[60-Day–12–0338] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

In compliance with the requirement 

of Section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995 for 

opportunity for public comment on 

proposed data collection projects, the 

Centers for Disease Control and 

Prevention (CDC) will publish periodic 

summaries of proposed projects. To 

request more information on the 

proposed projects or to obtain a copy of 

the data collection plans and 

instruments, call 404–639–7570 or send 

comments to Kimberly Lane, CDC 

Reports Clearance Officer, 1600 Clifton 

Road, MS D–74, Atlanta, GA 30333 or 

send an email to omb@cdc.gov. 

Comments are invited on: (a) Whether 

the proposed collection of information 

is necessary for the proper performance 

of the functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

ways to enhance the quality, utility, and 

clarity of the information to be 

collected; and (d) ways to minimize the 

burden of the collection of information 

on respondents, including through the 

use of automated collection techniques 

or other forms of information 

technology. Written comments should 

be received within 60 days of this 

notice. 

Proposed Project 

Annual Submission of the Ingredients 

Added to, and the Quantity of Nicotine 

Contained in, Smokeless Tobacco 

Manufactured, Imported, or Packaged in 

the U.S. (OMB No. 0920–0338, exp. 9/ 

30/2012)—Extension—Office on 

Smoking and Health, National Center 

for Chronic Disease Prevention and 

Health Promotion (NCCDPHP), Centers 

for Disease Control and Prevention 

(CDC). 

Background and Brief Description 

The oral use of smokeless tobacco 

(SLT) products represents a significant 

health risk. Smokeless tobacco products 

contain carcinogens which can cause 

cancer and a number of non-cancerous 

oral conditions, as well as leading to 

nicotine addiction and dependence. 

Furthermore, SLT use is not a safe 

substitute for cigarette smoking. 

Adolescents who use smokeless tobacco 

are more likely to become cigarette 

smokers. 

The Centers for Disease Control and 

Prevention (CDC), Office on Smoking 

and Health (OSH), has primary 

responsibility for the Department of 

Health and Human Services (HHS) 

smoking and health program. HHS’s 

overall goal is to reduce death and 

disability resulting from the use of 

smokeless tobacco products and other 

forms of tobacco through programs of 

information, education and research. 

The Comprehensive Smokeless 

Tobacco Health Education Act of 1986 

(CSTHEA, 15 U.S.C. 4401 et seq., Pub. 

L. 99–252) requires each person who 

manufactures, packages, or imports 

smokeless tobacco products to provide 

the Secretary of Health and Human 

Services (HHS) with a list of ingredients 

added to tobacco in the manufacture of 

smokeless tobacco products. CSTHEA 

further requires submission of the 

quantity of nicotine contained in each 

smokeless tobacco product. Finally, the 

legislation authorizes HHS to undertake 

research, and to report to Congress (as 

mstockstill on DSK4VPTVN1PROD with NOTICES